# The INFUSE - Anterior Myocardial Infarction (AMI) Study

> **NCT00976521** · NA · COMPLETED · sponsor: **Atrium Medical Corporation** · enrollment: 452 (actual)

## Conditions studied

- Acute Anterior Myocardial Infarction

## Interventions

- **DRUG:** Abciximab local infusion
- **OTHER:** No local infusion
- **PROCEDURE:** Thrombus aspiration

## Key facts

- **NCT ID:** NCT00976521
- **Lead sponsor:** Atrium Medical Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2012-02
- **Final completion:** 2013-04
- **Target enrollment:** 452 (ACTUAL)
- **Last updated:** 2013-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00976521

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00976521, "The INFUSE - Anterior Myocardial Infarction (AMI) Study". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00976521. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*